Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02255773 · ClinicalTrials.gov registry record · NA
Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral Measures
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02255773: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT02255773 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02255773, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of this research study is to learn more about fatigue and how it affects your behavior as well as your willingness to learn new behaviors.
Primary Outcome
Endpoint for Effort Expenditure for Rewards Task (EEfRT) is ratio of hard task choices (number of hard task choices/total choices) across levels of probability. Endpoints for associative learning task are number of trials until reaching the a priori defined learning criterion (three consecutive correct responses for each association), indicating goal-directed learning, and number of trials between reaching this criterion and reaching asymptote in the reaction times, indicating establishment of h
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Computerized Tasks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-11-04 |
| Est. Completion | 2024-03-27 |
| Phase | NA |
What the finished NCT02255773 record still lists
NCT02255773 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT02255773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02255773 about?
NCT02255773 is a clinical study titled "Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral Measures". The goal of this research study is to learn more about fatigue and how it affects your behavior as well as your willingness to learn new behaviors.
What is the current status of trial NCT02255773?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-11-04. Estimated completion is 2024-03-27.
What interventions are being tested in trial NCT02255773?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Computerized Tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT02255773?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02255773's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI